Oligonucleotide-Based Molecular Therapy for Restenosis after Angioplasty

E-ISSN： 1873-5592|4|8|613-618

ISSN： 1389-4501

Source： Current Drug Targets, Vol.4, Iss.8, 2003-11, pp. : 613-618

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nitric oxide-based molecular strategies for restenosis therapy

By Lin Chia-En Janero David R Garvey David S

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 5, 2005-05 ,pp. : 483-495

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological Approaches to the Prevention of Restenosis After Coronary Angioplasty

By Hamon M.

Drugs & Aging, Vol. 13, Iss. 4, 1998-10 ,pp. : 291-301

Adis International

Access to resources Recommend Favorite

Oligonucleotide-based Gene Therapy for Cardiovascular Disease Are Oligonucleotide Therapeutics Novel Cardiovascular Drugs

Current Drug Targets, Vol. 1, Iss. 1, 2000-07 ,pp. : 15-23

Bentham Science Publishers

Access to resources Recommend Favorite

Photopheresis: Therapeutic Potential in Preventing Restenosis After Percutaneous Transluminal Coronary Angioplasty

By Bisaccia E.

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 1, 2003-01 ,pp. : 43-51

Adis International

Access to resources Recommend Favorite

Glucocorticoids in the Prevention of Restenosis After Coronary Angioplasty: Therapeutic Potential

By Ferrero Valeria Ribichini Flavio Pesarini Gabriele Brunelleschi Sandra Vassanelli Corrado

Drugs, Vol. 67, Iss. 9, 2007-01 ,pp. : 1243-1255

Adis International

Access to resources Recommend Favorite